3.
Although venlafaxine is approved by the U.S. Food and Drug Administration (FDA) only for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder, double-blind and single-blind randomized, controlled clinical trials of venlafaxine monotherapy have shown it to be effective in all of the following additional conditions except